Molecular Technology 2019
DOI: 10.1002/9783527823987.vol2_c5
|View full text |Cite
|
Sign up to set email alerts
|

Engineering the Ribosomal Translation System to Introduce Non‐proteinogenic Amino Acids into Peptides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 83 publications
0
1
0
Order By: Relevance
“…As natural aminoacyl-tRNA synthetases (ARS) cannot efficiently charge nPAAs onto tRNAs, alternative methods for preparing nPAA-tRNAs are necessary. Accordingly, the following methodologies have been developed so far: (1) the use of an aminoacylation ribozyme named flexizyme, which is used in the studies by Katoh et al for the preparation of d -α- and β-aminoacyl-tRNAs [23,24,29,30,31], (2) charging nPAAs by means of mutant ARSs (used in the studies by Lee et al and Fan et al) [13,14,32,33,34,35,36], (3) the ligation of nPAA-pdCpA dinucleotides with tRNA lacking the 3′-terminal CA dinucleotide (used in the studies by Doi et al, Dedkova et al, and Maini et al) [12,19,37,38,39], and (4) the post-aminoacylation modification of PAA-tRNA (used in the study by Haruna et al) [1,17,40,41,42,43]. However, the details of these methodologies are discussed elsewhere [32].…”
Section: Perspectivesmentioning
confidence: 99%
“…As natural aminoacyl-tRNA synthetases (ARS) cannot efficiently charge nPAAs onto tRNAs, alternative methods for preparing nPAA-tRNAs are necessary. Accordingly, the following methodologies have been developed so far: (1) the use of an aminoacylation ribozyme named flexizyme, which is used in the studies by Katoh et al for the preparation of d -α- and β-aminoacyl-tRNAs [23,24,29,30,31], (2) charging nPAAs by means of mutant ARSs (used in the studies by Lee et al and Fan et al) [13,14,32,33,34,35,36], (3) the ligation of nPAA-pdCpA dinucleotides with tRNA lacking the 3′-terminal CA dinucleotide (used in the studies by Doi et al, Dedkova et al, and Maini et al) [12,19,37,38,39], and (4) the post-aminoacylation modification of PAA-tRNA (used in the study by Haruna et al) [1,17,40,41,42,43]. However, the details of these methodologies are discussed elsewhere [32].…”
Section: Perspectivesmentioning
confidence: 99%